X
09Oct

Caremark Round II: Beware Red Flags in Drug Development

Goodwin | | Return|
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/caremark-round-ii-beware-red-flags-in-18599/

Related

Costa Rica – Increase in the social security contribution towards Disability, Old Age and Death

On August 28, 2019, the amendment to Transitory XI of the social security contribution towards Disab...

Read More >

New York Lawmakers Expand Pay Equity Law and Ban Salary History Inquiries

On the heels of passing sweeping changes to New York’s harassment and discrimination laws, the stat...

Read More >

New Jersey Passes Wage Theft Law: Employers Beware

On August 6, 2019, Acting Governor Sheila Oliver signed into law the New Jersey Wage Theft Act (“WT...

Read More >

New UK Corporate Governance Reporting Requirements – Is Your UK Subsidiary Ready?

In 2020, we will start to see private UK companies including the new corporate governance and report...

Read More >

Have You Thought About Encrypting Your Company's Data, And Its Communications? Perhaps You Should

Alright. So, you’ve battened down the hatches of your company’s premises, to protect your employee...

Read More >

Japan Legal Update Vol. 51 | January–February 2020

Amendment to the Civil Code Will Come Into Effect in April - On April 1, 2020, the Act to Partiall...

Read More >